Audits, Monitoring and Safety Committees

Similar documents
2016 APHL BIOSAFETY AND BIOSECURITY SURVEY

2017 APHL BIOSAFETY AND BIOSECURITY SURVEY

Risk Assessment for the TB Laboratory

City of Boston Biological Safety Regulations and Laboratory Oversight

Biosafety in CDC Laboratories: The Path Forward

NLTC-9. Supporting Your Sentinel Laboratories

Administrative Policies and Procedures

NLTC 9. Utilizing Consortiums to Bridge Gaps in Biosafety Outreach. Crystal Fortune, BS(CLS) Montana Laboratory Services Bureau

Policy on Minors in Laboratories

3/15/2017. Predict, Prevent and Prepare: Improving Laboratory Biosafety and Biosecurity Across the Nation. Disclosure Statement.

Biosafety Level 3 Laboratories in the US: Common Practices and Operations

No Path? No Problem? Perspectives from a Public Health Laboratory

Implementing an Effective Biosafety Program

Quality Assurance and Regulatory Compliance Office and USAMRIID FDA Risk Management. Carolyn Mentzer Chief, QARCO

Main Topics. Biosafety in the Workplace. Introduction to Biosafety Principles. Historical Perspective. Biosafety. Biosecurity

II. Responsibilities

TRAINING. A. Hazard Communication/Right-to-Know Training

Ryan Burnette, Ph.D. Director, Alliance Biosciences

Practical Experience of Implementing New Laboratory Biorisk Standards in Indonesia

Biosafety and Exposure Control Plan

Ways to Improve Sentinel Lab Preparedness Participation. Lisa Wallace, Training & Evaluation Supervisor/STC/BSO NLTC 9 Conference June 30, 2017

Assuring Laboratory Biosecurity

This policy lays out the basic University principles and general roles and responsibilities in promoting a culture of safety.

Strengthening a Culture of Laboratory Safety

CDC/APHL Laboratory Biosafety Competencies for the BSL-2, BSL-3 and BSL-4 Laboratories

Advancing Biosafety Across the U.S. Clinical Laboratory Community

BIOSECURITY IN THE LABORATORY

Appendix I Safety Training Form

Emergency Planning: The Galveston National Laboratory. Joan E. Nichols PhD University of Texas Medical Branch Associate Director GNL Galveston, Texas

Evolution of a Team-Run BSL-3 Facility Maintenance Program

Department of Defense DIRECTIVE

WHO Laboratory Biosafety Manual Revision

EBOLA- THEN; NOW and FUTURE SIERRA LEONE

The Safety Audit. Safety Audits Why Bother? Oh no.. 4/26/2017. I need some help but where can I get it????? Does it really matter? I hate metrics!

Practicum Topics. Serving Size: 1 Practicum per Student Servings per e-magazine: 4. Hours per Week per Student Approximately 12. Campuses (Houston) 1

What is Safety & Compliance? Case Study of a Laboratory Accident Who Sets the Standards for Safety & Compliance Promoting a Culture of Safety Roles

Standards for Laboratory Accreditation

BOSTON PUBLIC HEALTH COMMISSION REGULATION BIOLOGICAL LABORATORY REGULATIONS

Laboratory Safety Coordinator Meeting. Fall 2011

Emergency Management Plan

Biological Weapons Convention Meeting of Experts. Geneva, Switzerland August WHO's. Dr Nicoletta Previsani

The WHO laboratory network to enhance laboratory biosafety and biosecurity in developing countries

HARVARD UNIVERSITY MINORS IN LABS POLICY STATEMENT

Culture of Safety at Boston University s Research Enterprise

SAFETY REQUIREMENTS UCLA DEPARTMENT OF CHEMISTRY AND BIOCHEMISTRY

TESTIMONY OF THOMAS HAMILTON DIRECTOR SURVEY & CERTIFICATION GROUP CENTER FOR MEDICAID AND STATE OPERATIONS CENTERS FOR MEDICARE & MEDICAID SERVICES

Safety Culture in Life Sciences Laboratories: Time for Action. Donald R. Callihan

Briefing for providers in relation to service development for inpatient service for Airborne High Consequence Infectious Diseases.

RESEARCH LABORATORIES CONDUCTING HIV/HBV RESEARCH AND PRODUCTION

Training Needs Assessment for EHS-Related Topics (Revised 11/17)

PRESENTORS Cyndi McCullough Andrew Yosten

Department Safety Coordinators together with Research Safety. Building a Safety Culture

Quality Management Program

Panel 1 Elastomeric Respirators: User Perspective

VIRGINIA TECH INSTITUTIONAL BIOSAFETY COMMITTEE

The Implementation of Biorisk compliance with International Standard

World Federation for Culture Collections ICCC-12 Conference Florianopolis, Brazil, 26 Sept 1 Oct Dr Nicoletta Previsani

Laboratory Assessment Tool

IMPLEMENTATION OF A BSL2 NORTHWESTERN UNIVERSITY. Iwona Spath, RBP Biological Safety Specialist Office for Research Safety

6/28/2016. Questions? Workshop 6 CAP Inspection Preparation Thursday, June 23, 2016

Conducting Mock Surveys for Risk Assessment: Infection Control and Prevention

Human Pathogens and Toxins Act: Bill C-11

Best Practices for IBCs in Challenging Times

Public Health Emergency Preparedness Cooperative Agreements (CDC) Hospital Preparedness Program (ASPR - PHSSEF) FY 2017 Labor HHS Appropriations Bill

Administrative Burden of Research Compliance

Welcome! Responsible EHS Compliance In Research. Presented by. Michael Gladle Director of Environmental Health and Safety

University of Notre Dame. Safety Program. Department of Physics Nieuwland Science Hall Eddy Street Lab.

Quality Laboratory Practice and its Role in Patient Safety

Medical Surveillance and Medical Event Reporting Technical Manual

THE. Summary. Illustration courtesy of the U.S. Army

Occupational Health and Medical Surveillance Program at NBACC

Template F-circle lt grey 1

University of Notre Dame

Emerging Infectious Diseases Preparedness and Response

Incident Planning Guide: Infectious Disease

Review of Categorizing Biological Agents In Postmortem Risk Groups Report. Maj Gen (Ret) George K. Anderson, MD, MPH

PROGRAM GUIDE - UNIVERSITY CLIA REGISTERED LABORATORIES COMPLIANCE COMMITTEE

SAINT LOUIS UNIVERSITY

BUILD EXITO Early Career Investigator Award Application

CAP Most Frequent Deficiencies and How to Avoid Them. March 11, 2015

Meeting the Challenges of BSL-2+

Biological Agents and Toxins Act: Development and Enforcement of Biosafety and Biosecurity in Singapore

UNIVERSITY OF CALIFORNIA, MERCED AUDIT AND ADVISORY SERVICES. Laboratory and Field Safety Report No. M15A011. December 18, 2015

Facility Tuberculosis (TB) Risk Assessment for Correctional Facilities

Laboratory System Improvement Program (L SIP)

Quality Assurance Program For Hospital Based Point of Care Testing. Presented by: Jeanne Mumford, MT(ASCP) Pathology Supervisor, QA Specialist

Increase/ General Fund Actual Approved Requested Recommended (Decrease) ~ $373,210 Add five positions.

Is Your Respirator Really Protecting You?

GOVERNMENT OF THE REPUBLIC OF SIERRA LEONE MINISTRY OF HEALTH AND SANITATION. National Infection Prevention and Control Policy

GUIDELINES FOR THE IMPLEMENTATION AND ENFORCEMENT OF BOSTON PUBLIC HEALTH COMMISSION S DISEASE SURVEILLANCE AND REPORTING REGULATION

PROJECT SCOPE STATEMENT

Registration Summary by Campus

THE PREVENTIVE CONTROLS RULES AND THE FSPCA

Personnel. From RLM, COM, GEN and TLC Checklists

UBC Workplace Safety Orientation

Building Quality into Clinical Trials. Amy C. Hoeper, MSN, RN, CCRC, Quality Manager Cincinnati Children s Gamble Program for Clinical Studies

Laboratory Safety Training

Leveraging Nursing Expertise with USP<800>

Clinical Guidance on the Identification and Evaluation of Possible SARS-CoV Disease among Persons Presenting with Community-Acquired Illness Version 2

COMMISSION ON LABORATORY ACCREDITATION. Laboratory Accreditation Program TEAM LEADER ASSESSMENT OF DIRECTOR & QUALITY CHECKLIST

Transcription:

Audits, Monitoring and Safety Committees Andrew Cannons, Ph.D. Laboratory Director FL Bureau of Public Health Laboratories-Tampa Outline Auditing The Biosafety Program Self Auditing, Internal Auditing, External Auditing Monitoring Staff and Equipment Reporting Incidents, Accidents, Near Misses Updating Your Biosafety Program Preparing for Novel Threats Safety Committees 1

Auditing Your Biosafety Program- Why? Need to Ensure the Program is Successful Need to Ensure the Program is Maintained, Improved Where Necessary Need to Ensure Staff Understand the Program and Show Compliance Auditing Your Biosafety Program- How? Pre Program Audit/Questionnaire Might be difficult if your program is already established Ongoing 2

Auditing Your Biosafety Program- Types? Internal Internal (PI, Safety Officer, Director) Self (Department Staff) External CLIA (not safety orientated) CAP CDC/APHIS (Select agent program) How to Monitor -Internal Auditing Use Checklists What To Monitor? How Detailed? Frequency of Audits Monthly, Yearly? How to Report Major Issues Minor Issues Recurring Issues Incident Reports Identify Issues Between Audits 3

How to Monitor -Internal Auditing APHL Biosafety Checklist Covers risk assessment, safety practices, PPE, lab practices, training, auditing Others Public Health Practice Asks about frequency of checks Checklist Should Also be Used to Ask Staff E.g. are they adequately trained? Comfortable in doing the work? Have all the safety controls in place (PPE, equipment, secondary barriers)? How to Monitor-Internal Auditing BSL3 Checklist Looks at Safety and Security Related Components Completed Each Month by PI All BSL3 Users Informed of Report Includes observations, deficiencies, timeline to rectify any deficiencies Recurring deficiencies addressed immediately 4

How to Monitor-Internal Auditing Incident Reports Documents All Incidents In BSL3 Labs Completed By Persons Involved/PI/RO Way to Identify: Corrective Action Recurring Issues Can Supplement CDC Form 3 Used to Update Biosafety, Incident Response, Security Manuals Addressing Recurring Themes Some Items on Your Audit Checklist Might Keep Repeating Need to Increase SOP Compliance? Some IRs Might Show Similar Trends Training Problem? Look at Your Training Program Do Not Use Punishment Reduce Reporting Behavioral Cues 5

Behavioral Cues How to Monitor-External Auditing External Audits, Surveys, Inspections Conducted By Agencies to Ensure Compliance Typically Compliance is Required For Continuation Audits Typically on a Defined Rotation (unless unannounced) Examples: CDC/APHIS Select Agent Program CLIA CAP NELAC Audits By Third Party Safety Agency Another Laboratory 6

How to Monitor-External Auditing College of American Pathologists Peer Based Inspection Model On-Site Inspection Every Two Years Some Safety Component Included How to Monitor-External Auditing CLIA Required for all entities that perform tests on... "materials derived from the human body for the purpose of providing information for the diagnosis, prevention or treatment of any disease or impairment of, or the assessment of the health of, human beings. Surveys conducted every two years Main emphasis on quality assessment rather than biosafety 7

How to Monitor-External Auditing CDC/APHIS Select Agent Program Federal Select Agent Program oversees the possession, use and transfer of biological select agents and toxins Enhances the nation s oversight of the safety and security of select agents CDC/APHIS Select Agent Program 8

Monitoring Staff and Equipment Performance Competency/Performance Evaluation of Staff Acknowledge the good, address the not so good (not punitively) Annual Biosafety Training and Evaluations Looking for understanding and compliance Annual Respiratory Protection Training and FIT Testing Drills and Exercises, With AAR Monitoring Staff and Equipment Performance, cont. Biosafety Equipment Must be Monitored Regularly for Efficacy PPE Respirators (e.g. filter use) Common Use Equipment Biological Safety Cabinets (air flow) Centrifuges BSL3 Labs Deficiencies Reported Immediately and Fixed 9

Reporting Incidents, Accidents, Near Misses All Incidents Involving Infectious Agents Should be Reported Via the Agency s Procedures Spill (minor, major) LAI Incident Report Should be Completed Workman s Compensation Possible Form 3 to Select Agent Program Reporting Incidents, Accidents, Near Misses, cont. Close Calls Are Wake Up Calls Keep a Log Book Where Staff Can Document Near Misses Use Information for Making Improvements to Your Biosafety Program 10

Updating Your Biosafety Program Use Audit Information/Reports Use Incident Reports, Near Miss Documentation Exercise Procedures, After Action Report Discuss Biosafety Issues at Safety Committee Meetings Training Attend National Training if Possible Webinars Update Plans Accordingly Preparing for Novel Threats Legionella pneumophila Norwalk virus MRSA Chikungunya MERS D68 Ebola Cryptosporidium HIV Campylobacter Toxic Shock Syndrome Helicobacter pylori E. coli O157 Prions VRE What is Next? Ehrlichia West Nile virus SARS Nipah virus Novel H1N1 11

Safety/Biosafety Committee Safety/Biosafety Committee Key to Maintaining Culture of Safety Commitment from Leadership Representation from Each Department Regular Meetings 12